Back to XTX Topco Ltd XTX Topco Ltd

MREOMREO
9 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in MEREO BIOPHARMA GROUP PLC

Yes. XTX Topco holds 174,481 shares of MREO (Mereo Biopharma Group), worth $55,433, as of its Q2 2026 13F filing. It increased the position by 90,012 shares (+106.6%) from Q1 2026. XTX Topco has held MREO since Q1 2026, across 2 quarterly 13F filings.

Current Value

$55,433

Current Shares

174,481

Total Value Change

+$40,839

Total Shares Change

+163,168

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
174,481
+106.6%
$55,4330.0%$0.32
33
2026-Q1
New
84,469
-
$27,8750.0%$0.41
27
2025-Q4
Exited
0
-100.0%
$00.0%$0.37
0
2025-Q3
Increased
191,037
+175.5%
$393,5360.0%$1.96
38
2025-Q2
New
69,341
-
$187,9140.0%$2.66
31
2025-Q1
Exited
0
-100.0%
$00.0%$2.30
0
2024-Q4
New
37,974
-
$132,9090.0%$3.52
31
2023-Q4
Exited
0
-100.0%
$00.0%$2.31
0
2023-Q3
New
11,313
-
$14,5940.0%$1.29
25

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used